Redeye sees a soft Q2 report from Stille, marked by headwinds in the surgical instruments business, including supply chain issues and the phase-out of certain products, resulting in temporary negative YoY growth.
ANNONS
Redeye sees a soft Q2 report from Stille, marked by headwinds in the surgical instruments business, including supply chain issues and the phase-out of certain products, resulting in temporary negative YoY growth.
